Craft

BioCorRx

Stock Price

$0.3

2024-10-29

Market Capitalization

$3.3 M

2024-10-29

Revenue

$797.2 K

FY, 2025

BioCorRx Summary

Company Summary

Overview
BioCorRx Inc. operates alcoholism rehabilitation and treatment centers in California. The company distributes and licenses BioCorRx Recovery Program for the treatment of alcoholism and opioid addiction consisting of a Naltrexone implant that is placed under the skin in the lower abdomen coupled with a counseling/life coaching program, including sessions from specialized life coaches and/or counselors. Its program is primarily used by independently owned and licensed clinics.
Type
Public
Status
Active
Founded
2008
HQ
Anaheim, CA, US | view all locations
Website
http://www.biocorrx.com/
Cybersecurity rating
Sectors

Key People

  • Kent Emry, Director

    • Lourdes Felix

      Lourdes Felix, CEO, CFO, Director

    • Luisa Ingargiola, Director

      • Louis Lucido

        Louis Lucido, President & Director

      LocationsView all

      2 locations detected

      • Anaheim, CA HQ

        United States

        2390 E Orangewood Ave #575

      • Santa Ana, CA

        United States

        Santa Ana, CA 92705, USA

      BioCorRx Financials

      Summary Financials

      Revenue (Q1, 2026)
      $214.5K
      Gross profit (Q1, 2026)
      $189.4K
      Net income (Q1, 2026)
      ($859.9K)
      Cash (Q1, 2026)
      $211.9K
      EBIT (Q1, 2026)
      ($956.0K)
      Enterprise value
      $4.6M

      Footer menu